Oramed Pharmaceuticals
ORMP
#9214
Rank
C$0.23 B
Marketcap
C$5.85
Share price
1.96%
Change (1 day)
76.39%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): C$87.17 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of C$87.53 Million, an increase over its 2024 earnings that were of -C$21.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$87.17 M-0.41%
2025 C$87.53 M-513.21%
2024 -C$21.19 Million-311.47%
2023 C$10.01 M-119.45%
2022 -C$51.51 Million39.17%
2021 -C$37.01 Million73.93%
2020 -C$21.28 Million18.53%
2019 -C$17.95 Million-16.62%
2018 -C$21.53 Million38.32%
2017 -C$15.57 Million12.51%
2016 -C$13.84 Million25.01%
2015 -C$11.07 Million18.18%
2014 -C$9.37 Million39.72%
2013 -C$6.71 Million46.4%
2012 -C$4.58 Million128.32%
2011 -C$2.01 Million-51.47%
2010 -C$4.14 Million35.21%
2009 -C$3.06 Million
2007 -C$4.81 Million607.04%
2006 -C$0.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
C$32.64 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$10.06 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.72 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$85.94 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C$49.04 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel